Health Care · In Vitro & In Vivo Diagnostic Substances · Nasdaq · CIK 73290 · FYE May 31 · Prices AT CLOSE 2026-08-20 (USD) Last $1.59 · Day +4.28% · Mkt cap $5M · 1Y −50.6% · Off 52W high −56.0% · Vol (1Y) 50.8% Price2023-08-21 → 2026-08-20 BMRA close: $9.4 on 2023-08-21 to $1.6 on 2026-08-20. Split-adj closes · 240 of 5,309 · price returnⓘ At a glance | Short interest0.7% of sh out | | Days to cover3.6d | | 13F net flow (QoQ)+1.02% | | Top-10 13F concentration100.0% | | Next report (est.)2026-10-10 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$4.3M | | Earnings (TTM)-$4.2M | | ROE−93.0% | | Net margin−93.6% | | ROIC−196.7% | | Sales growth 3Y−34.5% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−37.1% | | 1Y−50.6% | | 3Y−83.2% | | 5Y−94.9% | | 10Y−93.9% | | Since incept. (ann.)−4.9% |
Total return · from 2005-07-11ⓘ Risk | Ann. volatility (1Y)50.8% | | Ann. volatility (3Y)110.8% | | Sharpe (1Y)−1.00 | | Sharpe (3Y)−0.07 | | Max drawdown (1Y)−57.1% | | Max drawdown (3Y)−88.7% | | Beta (3Y vs SPY)1.54 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| GEODE CAPITAL MANAGEMENT, LLC | 56,042 | $118,256 | 1.86% | +200.9% | | BlackRock, Inc. | 18,636 | $39,508 | 0.62% | +0.0% | | VANGUARD CAPITAL MANAGEMENT LLC | 14,514 | $30,625 | 0.48% | new | | LPL Financial LLC | 10,849 | $23,000 | 0.36% | new | | VANGUARD FIDUCIARY TRUST CO | 6,613 | $13,953 | 0.22% | new | | HOLLENCREST CAPITAL MANAGEMENT | 825 | $1,749 | 0.03% | −43.1% | | UBS Group AG | 519 | $1,100 | 0.02% | −91.1% | | HARBOUR INVESTMENTS, INC. | 125 | $265 | 0.00% | +0.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-04-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-02-28 | 2026-04-13 | −$0.44 | — | $987,000 | −11.8% | | 2025-11-30 | 2026-01-14 | −$0.45 | — | $1.2M | −26.0% | | 2025-08-31 | 2025-10-14 | $0.00 | — | $1.4M | −23.6% | | 2025-05-31 | 2025-08-29 | — | — | $749,000 | −33.0% |
As-reported XBRL · next 2026-10-10 est.ⓘ Segment mixFY2025 (ended May 2025) Asia 32% · North America 31% · Europe 24% · Middle East 12% · South America 0% geographic · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
